[EN] CRYSTALLINE SALTS OF CORYDALMINE<br/>[FR] SELS CRISTALLINS DE CORYDALMINE
申请人:YANG ZHENG
公开号:WO2020108330A1
公开(公告)日:2020-06-04
The present disclosure relates to crystalline salt forms of the following Compound (1), also known as l-corydalmine or l-CDL, and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in methods for the treatment of chronic pain, anxiety, insomnia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome, et al.